Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high36.350 17/01/17
52 week low26.000 28/09/16
52 week change -0.250 (-0.85%)
4 week volume8,598,756 23/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 8190K Sinclair Pharma PLC 12 July 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: SINCLAIR PHARM...

Hardman Research: Promising start in the US

RNS Number: 7651K Sinclair Pharma PLC 12 July 2017 Hardman Research: Promising start in the US Promising start in the US - In 2016 Sinclair was transformed into a streamlined, pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-lasting, natural looking, minimally invasive treatm...

Sinclair Pharma lifts sales in 6 months to 30 June

Sinclair Pharma said its unaudited sales for the six months to 30 June were 20m, compared with sales of 17.2m for the sam...

Sinclair Pharma lifts sales in 6 months to 30 June

Trading Update for the 6 months to 30 June 2017

RNS Number: 6038K Sinclair Pharma PLC 11 July 2017 Trading Update for the 6 months to 30 June 2017 16% growth in revenues to 20 million FDA approves Silhouette label change accelerating growth potential On track for another year of strong growth London, 11 July 2017 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics co...

Holding(s) in Company

RNS Number: 1211K Sinclair Pharma PLC 05 July 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: SINCLAIRPHARM...

Sinclair Pharma acquires rights to the Refine Support System

Sinclair Pharma has acquired the Refine Support System for a total consideration of up to $11.3m including regulatory and...

Acquisition

RNS Number: 4019I Sinclair Pharma PLC 19 June 2017 Sinclair Pharma plc Acquisition of Worldwide rights to the Refine Support System, an FDA cleared suture based breast-lifting technology Provides immediate access to a $600 million segment of the US aesthetic market via Thermi's sales infrastructure Expands and complements Sinclair's portfolio of premium a...

Fundamental DataMore

EPS-5.9
Dividend yield0 %

Equity Research (SPH)

hardman & co
Sinclair Pharma plc
12/07/2017
In 2016 Sinclair was transformed into a streamlined, pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-lasting,...
hardman & co
Sinclair Pharma plc
28/03/2017
During 2016, Sinclair has been transformed into a streamlined pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-...
hardman & co
Sinclair Pharma plc
08/11/2016
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...

Latest discussion posts More

  • Re: ohhhhh

    I.M.O. Tosca is not out of the game at all. They sold 5% of Sinclair down to 24.5% but they are now buying again. I think they sold those 5% to ?a friend?, knowing that in ...
    6-Jul-2017
    Ambiorix1
  • ohhhhh

    spoke to soon back down now.....!!! Madoff jnr
    3-Jul-2017
    Madoff Jnr
  • umm,nice rise friday

    Wonder why the s/p went up 2p today...? I go all the way back to Medeva years and years ago (please don't remind me how long) then it was I.S. pharma I think,then Sinclair I S ...
    2-Jul-2017
    Madoff Jnr

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..
LLOYDS GRP.41%
BP24%
VODAFONE GRP.23%
BARCLAYS23%
GLAXOSMITHKLINE22%

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH